Covered recipient · General Payments record
SHYAM C SHIVDASANI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$10,173.99
- Reported across 586 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $223.46 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $35.72 | 2 |
| Novo Nordisk AS | $32.58 | 2 |
| Abbott Laboratories | $31.78 | 1 |
| GlaxoSmithKline, LLC. | $29.44 | 1 |
| Astellas Pharma US Inc | $26.32 | 1 |
| Azurity Pharmaceuticals, Inc. | $24.79 | 1 |
| Amgen Inc. | $22.85 | 1 |
| ABBVIE INC. | $19.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $31.78 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124805358 | CMS |
| ABBVIE INC. | $19.98 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106089910 | CMS |
| Amgen Inc. | $22.85 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117683266 | CMS |
| Astellas Pharma US Inc | $26.32 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139312384 | CMS |
| Azurity Pharmaceuticals, Inc. | $24.79 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134012719 | CMS |
| GlaxoSmithKline, LLC. | $29.44 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116273834 | CMS |
| Kowa Pharmaceuticals America, Inc. | $17.37 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113470557 | CMS |
| Kowa Pharmaceuticals America, Inc. | $18.35 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113470559 | CMS |
| Novo Nordisk Inc | $16.62 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097284364 | CMS |
| Novo Nordisk Inc | $15.96 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096650639 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.